Tag Archives: biotech industry

The New Road to IPO in the Age of the JOBS Act

President Obama

Not surprisingly, sessions discussing the topic of IPOs at this year’s BIO Investor Forum, tend to fill the room. Furthermore, it should surprise no one that this year’s IPO discussions were upbeat. That is mostly attributable to the dramatically higher number of IPOs that have already occurred this year. Furthermore, according to Jeff Baumel, moderator of a panel covering this very topic, deals are closing faster this year – with a median time of just Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Biotech IPO Boom or Bubble? The Opening Plenary at the BIO Investor Forum

David Thomas

With 31 (and counting) life sciences companies having already placed IPOs on the market within the first 8 months of this year and many others lining up for S-1 filings, biotech is buzzing about a revival of the IPO market. Is it a bubble? David Thomas, director of Industry Research and Analysis at BIO took up these questions during the opening plenary lunch of the 12th Annual BIO Investor Forum. What’s his short answer? Not Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Golden Rice Petition Draws 5,000+ Supporters

golden-rice3-115x76

If the authors of the Change.org petition condemning the destruction of Golden Rice field trials intended for the outrage to go viral, they have succeeded.  As this blog is posted, 5,239 people have signed onto the petition – most from the scientific community and added their comments urging that scientific advances not be impeded by uninformed activists. In addition, the furor in the media arena and blogosphere continues. Mark Lynas, UK-based environmentalist and former anti-GMO Read More >

Farmer Gene  |  1 Comment  |  Email This Post
Tags: , , , , , , , ,

The Return of the Biotech IPO

Graph

It isn’t just the volume of IPOs this summer that makes this window a victory for hibernating private biotechs and their VC backers, it’s the details of the offerings in terms of price, performance, and type of biotech making the leap onto the public stage. For the last five years we have not seen average offering prices land above expectations, but 2013 is breaking that trend. Price performance is also impressive, with a number of Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , ,

Have Questions About GMOs? We Know How to Get the Answers.

GMO-Answers1 copy

The ag biotech community – companies, scientists, health experts, farmers, industry organizations – have come together launching a new initiative to provide accurate information and answer the toughest questions about GMOs and how our food is grown. GMO Answers (www.GMOAnswers.com) is a new conversation, public Q&A, and central online resource for information on GMOs, their background, use in agriculture, and research and data in one easy-to-access public resource for the first time. “Food is personal, Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,